ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Human CD8+CD28– Ts Cells Expanded by Common Gamma Chain (γc) Cytokines Keep Steady Allospecific Suppressive Capacity In Vivo

G. Liu,1 F. Feng,1 P. Zhu,1 J. Liu,2 Y. Liu,1 Y. Yu.2

1Department of Immunology, School of Basic Medical Science, Southern Medical University, Guangzhou, Guangdong, China
2Department of Urology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.

Meeting: 2018 American Transplant Congress

Abstract number: A402

Keywords: Immunosuppression, Tolerance

Session Information

Session Name: Poster Session A: Tolerance / Immune Deviation

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Background: CD8+CD28– T suppressor (Ts) cells were recently reported to play a critical role in transplant tolerance, harnessing the potential for clinical use in transplantation. Here, we report a novel strategy to generate plenty of human CD8+CD28– Ts cells and debate their immune suppression capacity in vitro and in vivo, their origin and phenotypic characteristics.

Methods: Purified CD8+ T cells from PBMCs of individual A were stimulated with APCs (CD2– cells from PBMCs) from HLA-A, -B, -DR mismatched individual B in the presence of IL-2, IL-7, IL-15. After 9 days co-culture, cells were further selected and defined as CD8+CD28– Ts cells. Then, the CFSE-labeled CD4+ T cells from individual A were co-cultured with B-APCs or I-APCs (HLA-A, -B, -DR mismatched with individual A and B) in the presence of CD8+CD28– Ts cells. After 7 and 11 days, CFSE dilution assay was used to assess the suppressive capacity of CD8+CD28– Ts cells. Similarily, different cell populations were injected into NOG mice via i.p. to assess the in vivo suppressive capacity of CD8+CD28– Ts cells by flow cytometry and immunohistochemistry staining methods. At last, the phenotypic characteristics of CD8+CD28– T cells before and post-expanded were analyzed by flow cytometry.

Results: Following exposure to B-APCs, there was an evident decrease in the proliferating of CD4+ T cells on day 7 and day 11 in the presence of Ts cells, compared with in absence of CD8+CD28– Ts cells (P<0.01). Additionally, CD8+CD28– Ts cells did not obviously inhibit the proliferation of CD4+ T cells stimulated by I-APCs (P<0.01). Moreover, when CD8+CD28– Ts cells were transferred into NOG mice, their allospecific suppressive capacity kept steady and they still kept alive on day 11. Besides, the CD8+CD28– Ts cells up-regulated co-inhibitory molecule TIM3, whereas down-regulated cytotoxicity related molecules perforin, granzyme B, etc., implying possible suppressive mechanisms.

Conclusions: In vitro expanded human CD8+CD28– Ts cells by common γc cytokines with donor APCs possessed remarkable donor specific suppressive capacity not only in vitro but also in vivo circumstances. These findings may facilitate CD8+CD28– Ts cells based immune tolerance induction and monitor in clinical transplantation in future.

CITATION INFORMATION: Liu G., Feng F., Zhu P., Liu J., Liu Y., Yu Y. Human CD8+CD28– Ts Cells Expanded by Common Gamma Chain (γc) Cytokines Keep Steady Allospecific Suppressive Capacity In Vivo Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Liu G, Feng F, Zhu P, Liu J, Liu Y, Yu Y. Human CD8+CD28– Ts Cells Expanded by Common Gamma Chain (γc) Cytokines Keep Steady Allospecific Suppressive Capacity In Vivo [abstract]. https://atcmeetingabstracts.com/abstract/human-cd8cd28-ts-cells-expanded-by-common-gamma-chain-c-cytokines-keep-steady-allospecific-suppressive-capacity-in-vivo/. Accessed May 13, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences